Antibiotic Use in Suspected and Confirmed COVID-19 Patients Admitted to Health Facilities in Sierra Leone in 2020-2021: Practice Does Not Follow Policy.
Antibiotic Use in Suspected and Confirmed COVID-19 Patients Admitted to Health Facilities in Sierra Leone in 2020-2021: Practice Does Not Follow Policy.
复制标题
DOI:
10.3390/ijerph19074005
复制
发表时间:
2022-03-28
影响因子:
--
通讯作者:
Zachariah R
中科院分区:
文献类型:
--
作者:
Kamara IF;Kumar AMV;Maruta A;Fofanah BD;Njuguna CK;Shongwe S;Moses F;Tengbe SM;Kanu JS;Lakoh S;Mansaray AHD;Selvaraj K;Khogali M;Zachariah R
Inappropriate use of antibiotics during the COVID-19 pandemic has the potential to increase the burden of antimicrobial resistance. In this study, we report on the prevalence of antibiotic use and its associated factors among suspected and confirmed COVID-19 patients admitted to 35 health facilities in Sierra Leone from March 2020–March 2021. This was a cross-sectional study using routinely collected patient data. Of 700 confirmed COVID-19 patients, 47% received antibiotics. The majority (73%) of the antibiotics belonged to the ’WATCH’ group of antibiotics, which are highly toxic and prone to resistance. The most frequently prescribed antibiotics were azithromycin, ceftriaxone, amoxicillin, metronidazole, and amoxicillin-clavulanic acid. Antibiotic use was significantly higher in patients aged 25–34 years than in those with severe disease. Of 755 suspected COVID-19 patients, 61% received antibiotics, of which the majority (58%) belonged to the ‘WATCH’ category. The most frequently prescribed antibiotics were ceftriaxone, metronidazole, azithromycin, ciprofloxacin, and amoxycillin. The prevalence of antibiotic use among suspected and confirmed COVID-19 patients admitted to healthcare facilities in Sierra Leone was high and not in line with national and WHO case management guidelines. Training of health care providers, strengthening of antimicrobial stewardship programs, and microbiological laboratory capacity are urgently needed.
登录
查看更多内容
影响因子:
34.3
作者:
Hsia, Yingfen;Lee, Brian R.;Gawrys, G.
通讯作者:
Gawrys, G.
影响因子:
3.5
作者:
Kabba JA;James PB;Li Z;Hanson C;Chang J;Kitchen C;Jiang M;Zhao M;Yang C;Fang Y
通讯作者:
Fang Y
影响因子:
3.4
作者:
Nam Vinh Nguyen;Nga Thi Thuy Do;Lewycka, Sonia
通讯作者:
Lewycka, Sonia
影响因子:
158.5
作者:
Grein, J.;Ohmagari, N.;Flanigan, T.
通讯作者:
Flanigan, T.
影响因子:
3.7
作者:
Calderón-Parra J;Muiño-Miguez A;Bendala-Estrada AD;Ramos-Martínez A;Muñez-Rubio E;Fernández Carracedo E;Tejada Montes J;Rubio-Rivas M;Arnalich-Fernandez F;Beato Pérez JL;García Bruñén JM;Del Corral Beamonte E;Pesqueira Fontan PM;Carmona MDM;Fernández-Madera Martínez R;González García A;Salazar Mosteiro C;Tuñón de Almeida C;González Moraleja J;Deodati F;Martín Escalante MD;Asensio Tomás ML;Gómez Huelgas R;Casas Rojo JM;Millán Núñez-Cortés J;SEMI-COVID-19 Network
通讯作者:
SEMI-COVID-19 Network